Skip to main content

Table 2 Clinical characteristics of the TCGA PRAD cohort and the preselected subcohort

From: Random forest-based modelling to detect biomarkers for prostate cancer progression

 

TCGA PRAD

TCGA PRAD subcohort

Full cohort

Good prognosisa

Poor prognosisa

n

477

27

57

Age (mean ± sd)

61.06 ± 6.9

57.23 ± 6.7

62.46 ± 6

Stage (path. T)

 n.a.

6

0

0

 pT2a

13

1

0

 pT2b

6

3

0

 pT2c

161

23

0

 pT3a

153

0

24

 pT3b

129

0

31

 pT4

9

0

2

Gleason score

 6

43

6

0

 7

243

17

12

 8

61

2

8

 9

127

2

36

 10

3

0

1

  1. n.a. not available
  2. aGood prognosis defined as lack of BCR for at least 5 years and stage < pT3. Poor prognosis defined as BCR within 3 years and stage ≥ pT3
Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us